AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7034161
Drug: Intramuscular testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular testosterone (Triolandren, 348 mg)
Trial: 7034161
Drug: Testosterone propionate
RxNorm normalized name: Testosterone Propionate
DrugBank: Testosterone propionate (DB01420)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone propionate injections (84 mg every other day)
Trial: 7034161
Drug: Peroral testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peroral testosterone administration (800 mg micronized free testosterone daily)
Trial: 31455936
Drug: Dependence on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dependence on drug retailers, self-medication, and traditional healers
Trial: 15126538
Drug: Metformin and
RxNorm normalized name: metformin and acarbose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin and resistance training three times a week
Trial: 2792461
Drug: 1 alpha‐OHD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 alpha‐OHD group (0.75 micrograms of 1 alpha‐OHD and 400 mg of calcium daily)
Trial: 2792461
Drug: Thiazide group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazide group (1 alpha‐OHD, calcium and 4 mg of trichlormethiazide)
Trial: 2792461
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment for osteoporosis)
Trial: 800385
Drug: 0.05% diflorasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% diflorasone diacetate cream
Trial: 22926233
Drug: Zileuton ER
RxNorm normalized name: zileuton Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zileuton ER 2400 mg/d
Trial: 19522258
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (M group, n=29)
Trial: 15191153
Drug: Lidocaine intradermal
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine intradermal injection
Trial: 15191153
Drug: Saline intradermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline intradermal injection (Control)
Trial: 11703413
Drug: GP V‐specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GP V‐specific antibodies
Trial: 7868978
Drug: Dietary cholesterol
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary cholesterol 0 mg (no fat, no cholesterol)
Trial: 7868978
Drug: Dietary cholesterol
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary cholesterol 140 mg
Trial: 7868978
Drug: Dietary cholesterol
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary cholesterol 280 mg
Trial: 7868978
Drug: Dietary cholesterol
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary cholesterol 710 mg
Trial: 29306945
Drug: Weekly semistandardized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly semistandardized e‐mail feedback from psychologists (individual counseling)
Trial: 27874934
Drug: High-frequency oscillatory
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-frequency oscillatory ventilation combined with inhalational NO therapy
Trial: 20004661
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg farglitazar
Trial: 20004661
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg farglitazar
Trial: 12677095
Drug: Drug-free hydrophilic
RxNorm normalized name: PSYLLIUM HYDROPHILIC MUCILLOID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-free hydrophilic microemulsion (ME)
Trial: 12677095
Drug: Drug-free lipophilic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-free lipophilic microemulsion (ME)
Trial: 12677095
Drug: 5% salicylic
RxNorm normalized name: salicylic acid 285 mg in 1 mL TOPICAL SOLUTION [28.5% Salicylic Acid]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% salicylic acid gel
Trial: 14728001
Drug: Oral glycoprotein
RxNorm normalized name: Zaire ebolavirus envelope glycoprotein Injection [Ervebo]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glycoprotein IIb/IIIa inhibitors
Trial: 25695061
Drug: Dexamethasone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (8 mg before induction of anesthesia)
Trial: 25695061
Drug: Subhypnotic propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subhypnotic propofol (1 mg/kg/h during operation)
Trial: 25695061
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (10% intralipid infusion)
Trial: 15364042
Drug: Lamotrigine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (400 mg/day)
Trial: 11056241
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (HRT) as a daily oral dose of estradiol, 2 mg, and norethisterone acetate, 1 mg, plus monthly subcutaneous implants of goserelin acetate for up to 2 years.
Trial: 11056241
Drug: Monthly subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly subcutaneous implants of goserelin acetate for up to 2 years without HRT.
Trial: 8822684
Drug: Clonidine patch
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine patch delivering 0.2mg/d
Trial: 30137193
Drug: Lefitolimod maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lefitolimod maintenance therapy
Trial: 27437913
Drug: L-thyroxine for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-thyroxine for 3-6 months
Trial: 18275866
Drug: Injection duration
RxNorm normalized name: clonidine Injection [Duraclon]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection duration of 25 s
Trial: 18275866
Drug: Injection duration
RxNorm normalized name: clonidine Injection [Duraclon]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection duration of 30 s
Trial: 18275866
Drug: Injection duration
RxNorm normalized name: clonidine Injection [Duraclon]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection duration of 35 s
Trial: 18275866
Drug: Injection duration
RxNorm normalized name: clonidine Injection [Duraclon]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection duration of 40 s
Trial: 18275866
Drug: Injection duration
RxNorm normalized name: clonidine Injection [Duraclon]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection duration of 45 s
Trial: 7513512
Drug: Tranilast 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tranilast 300 mg daily for 6 to 7 weeks before the onset of the pollen season and continuously during the season
Trial: 7513512
Drug: No medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medication including tranilast until the onset of clinical symptoms in season
Trial: 3743153
Drug: albuterol administered
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: albuterol administered by metered‐dose inhaler
Trial: 3743153
Drug: albuterol administered
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: albuterol administered by ultrasonic nebulizer
Trial: 3743153
Drug: Freon (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Freon (placebo effect from metered‐dose inhaler)
Trial: 3743153
Drug: isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: isotonic saline solution (placebo effect from ultrasonic nebulizer)
Trial: 18672629
Drug: 0.9 mg
RxNorm normalized name: estradiol 0.9 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 mg of atropine plus 2.5 mg of neostigmine
Trial: 18672629
Drug: 1.2 mg
RxNorm normalized name: RNA 1.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 mg of atropine plus 2.5 mg of neostigmine
Trial: 11147930
Drug: Amantadine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine treatment
Trial: 8741958
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg cocaine
Trial: 8741958
Drug: 0.4 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg/kg cocaine
Trial: 8741958
Drug: 5.0 mg
RxNorm normalized name: RUXOLITINIB 5.0 mg ORAL TABLET [JAKAFI]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0 mg placebo
Trial: 26537369
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no topical antibiotics)
Trial: 29615058
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (rhGH) treatment
Trial: 27050475
Drug: Early intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early intervention treatment
Trial: 25651378
Drug: Midazolam (CYP3A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (CYP3A probe drug)
Trial: 23842591
Drug: Low-dose triiodothyronine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose triiodothyronine (0.5 mcg/kg orally every 24 hr for 3 days)
Trial: 23842591
Drug: High-dose triiodothyronine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose triiodothyronine (0.5 mcg/kg orally every 12 hr for 3 days)
Trial: 20702794
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate at therapeutic levels (0.4‐0.8 mEq/L)
Trial: 20702794
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate at subtherapeutic levels (0.2‐0.4 mEq/L)
Trial: 16263254
Drug: beta(2)-agonist therapy
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta(2)-agonist therapy
Trial: 14597974
Drug: Recombinant Nematode
RxNorm normalized name: Recombinant nematode anticoagulant protein-2
DrugBank: Anpocogin (DB06552)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) at doses ranging from 0.3 to 5 micro g/kg
Trial: 14597974
Drug: Recombinant Nematode
RxNorm normalized name: Recombinant nematode anticoagulant protein-2
DrugBank: Anpocogin (DB06552)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant Nematode Anticoagulant Protein c2 (rNAPc2)
Trial: 1486159
Drug: Lignocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine spray 50 mg (Group A)
Trial: 1486159
Drug: Lignocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine spray 100 mg (Group B)
Trial: 1486159
Drug: Lignocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine spray 200 mg (Group C)
Trial: 1486159
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no lignocaine spray)
Trial: 23265758
Drug: Novel injection
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Novel injection approach
Trial: 23265758
Drug: Conventional injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional injection approach
Trial: 21764203
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of warfarin without interruption (group 1)
Trial: 21764203
Drug: Warfarin bridged
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin bridged with low-molecular-weight heparin (group 2)
Trial: 21764203
Drug: Warfarin bridged
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin bridged with unfractionated heparin (group 3)
Trial: 19295955
Drug: Carbohydrate-electrolyte drink
RxNorm normalized name: CARBOHYDRATE/ELECTROLYTES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate-electrolyte drink containing 36.2 mmol/L sodium (HNa)
Trial: 19295955
Drug: Carbohydrate-electrolyte drink
RxNorm normalized name: CARBOHYDRATE/ELECTROLYTES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate-electrolyte drink containing 19.9 mmol/L sodium (LNa)
Trial: 14759641
Drug: Acetyl L-carnitine
RxNorm normalized name: Nature's Way Acetyl L-Carnitine Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl L-carnitine (ALCAR) 1 g twice daily
Trial: 9447899
Drug: Meropenem (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem (1 g t.i.d.)
Trial: 9447899
Drug: Imipenem/cilastatin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem/cilastatin (1 g t.i.d.)
Trial: 7639373
Drug: Subcutaneous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous lidocaine (10 mL 1%)
Trial: 7639373
Drug: Subfascial lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subfascial lidocaine (10 mL 1%)
Trial: 3358883
Drug: Calcium carbimide
RxNorm normalized name: calcium carbimide
DrugBank: Calcium carbimide (DB09116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium carbimide (CC) 50 mg
Trial: 29438682
Drug: Serum copper
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum copper concentrations >24 μmol/L
Trial: 17136298
Drug: Leukotriene antagonists
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Leukotriene antagonists (LTA)
Trial: 17136298
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids + long‐acting Beta2 agonists
Trial: 8821373
Drug: Memantine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine (20 mg, single-dose application)
Trial: 1563211
Drug: Misoprostol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol (200 micrograms as a single dose or q.i.d. as a multiple dose)
Trial: 1563211
Drug: Indomethacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (100 mg single-dose administration or 50 mg t.i.d. multiple-dose administration)
Trial: 6860527
Drug: Long-acting propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting propranolol 160 mg daily
Trial: 6860527
Drug: Conventional propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional propranolol 80 mg twice daily
Trial: 6860527
Drug: Conventional propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional propranolol 160 mg daily
Trial: 29807629
Drug: Subdissociative intravenous-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subdissociative intravenous-dose ketamine (SDK) at 0.3 mg/kg
Trial: 29807629
Drug: Morphine at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine at 0.1 mg/kg
Trial: 27560168
Drug: Pioglitazone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (30 mg for 4 weeks, then 45 mg for 8 weeks)
Trial: 24493296
Drug: Single-stage treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-stage treatment (laparoscopic cholecystectomy and CBD exploration at the same operation)
Trial: 24493296
Drug: Two-stage treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-stage treatment (endoscopic stone clearance followed by laparoscopic cholecystectomy 2-5 days later)
Trial: 24493296
Drug: Single-stage treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-stage treatment
Trial: 19261314
Drug: Artesunate+sulfadoxine/pyrimethamine (AS+SP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artesunate+sulfadoxine/pyrimethamine (AS+SP) (4 mg/kg AS for 3 consecutive days+25 mg sulfadoxine on Day 0)
Trial: 19261314
Drug: Praziquantel (PZQ)
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Praziquantel (PZQ) (40 mg/kg)
Trial: 7922999
Drug: Transcatheter arterial
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcatheter arterial embolization (TAE) with cisplatin (50 mg) mixed with Lipiodol (5-15 ml) and gelfoam pieces.
Trial: 3072223
Drug: Nifedipine 5
RxNorm normalized name: nifedipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 5 mg 3 times daily
Trial: 12501067
Drug: Active magnets
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active magnets (500 G) applied to abdominal trigger points for 24 hours per day for 4 weeks
Trial: 31756716
Drug: Mindfulness training
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mindfulness training with daily text prompts to practice mindfulness for 10 minutes
Trial: 29846278
Drug: Cooling treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooling treatment (cooling gel cuff)
Trial: 24687385
Drug: PTH(1-84) 100
RxNorm normalized name: PTH
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: PTH(1-84) 100 μg/d s.c.
Trial: 22583743
Drug: Dry powder
RxNorm normalized name: Dry Powder Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dry powder device for inhaled tobramycin
Trial: 18848176
Drug: Electronic monitoring
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electronic monitoring of drug adherence (Medication Event Monitoring System)
Trial: 12439472
Drug: Index of
RxNorm normalized name: gr pol-orc/sw ver/rye/Kent/tim 100 index of reactivity SUBLINGUAL TABLET, SUBLINGUAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Index of Orthodontic Treatment Need (IOTN) instruction
Trial: 10037249
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment at a daily dose of 0.1 IU/kg (n=26) or 0.2 IU/kg (n=7) body weight
Trial: 7127998
Drug: Clonidine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.1 mg b.i.d. for 12 weeks, increased to 0.2 mg for 12 weeks)
Trial: 7127998
Drug: Hydrochlorothiazide (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (24 mg b.i.d. for 12 weeks, increased to 50 mg for 12 weeks)
Trial: 17218618
Drug: Continuous Positive
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous Positive Airway Pressure (CPAP) therapy for 4 to 6 weeks
Trial: 17218618
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with OSA before CPAP therapy
Trial: 15891124
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg thalidomide daily for one week, followed by 50 mg/day for weeks 2 and 3, then dummy capsules in weeks 4 through 7.
Trial: 15891124
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg thalidomide daily for one week, followed by gradual decrements every two weeks.
Trial: 9585310
Drug: Clonidine 0.2-0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.2-0.3 mg per os
Trial: 7712843
Drug: 120mg calcium
RxNorm normalized name: ubidecarenone 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120mg calcium daily
Trial: 7712843
Drug: 240mg calcium
RxNorm normalized name: acetaminophen 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240mg calcium daily
Trial: 7712843
Drug: 1g calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1g calcium daily
Trial: 7712843
Drug: 2g calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2g calcium daily
Trial: 2719293
Drug: 0.5 ml
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 ml saline solution and 0.5 ml clonidine (75 micrograms)
Trial: 2719293
Drug: 1 ml
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml clonidine (150 micrograms)
Trial: 2719293
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of 0.5% hyperbaric tetracaine (HT) + 1 ml isotonic saline
Trial: 29654915
Drug: MaZiRenWan (MZRW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MaZiRenWan (MZRW) 7.5 g, twice daily
Trial: 29654915
Drug: Senna 15
RxNorm normalized name: Senna 15 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Senna 15 mg daily
Trial: 16840386
Drug: Enalapril (ACE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (ACE inhibitor group)
Trial: 16840386
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy with ferrous sulfate, 525 mg
Trial: 12867205
Drug: Methadone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone treatment (mean daily dose 50 mg) in general practice